Chronic Gouty Arthritis — Patent Landscape
2
Approved drugs
46
Active US patents
74/100
Avg vulnerability
—
Annual revenue covered
Originators in Chronic Gouty Arthritis
Cliff calendar — next 15 years
11
28
7
29
17
33
1
34
5
36
1
37
4
39
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Colcrys
COLCHICINE
|
Scilex Pharms | 41 | 72 | — | 2028-10-06 |
|
Col-Probenecid
probenecid
|
Pfizer Inc. | 5 | 76 | — | 2029-06-03 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 7795243 | Col-Probenecid | method of use | 81 | 2029-06-03 |
| 8093297 | Colcrys | method of use | 80 | 2028-10-06 |
| 7964647 | Colcrys | method of use | 80 | 2028-10-06 |
| 8093298 | Colcrys | method of use | 80 | 2028-10-06 |
| 7964648 | Colcrys | method of use | 80 | 2028-10-06 |
| 7981938 | Colcrys | method of use | 80 | 2028-10-06 |
| 8093296 | Colcrys | method of use | 80 | 2028-10-06 |
| 8097655 | Colcrys | method of use | 80 | 2028-10-06 |
| 8415396 | Colcrys | method of use | 80 | 2028-10-06 |
| 8415395 | Colcrys | method of use | 80 | 2028-10-06 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 10226423 | Colcrys | formulation | 42 | 2037-12-20 |
| 9907751 | Colcrys | formulation | 42 | 2036-11-22 |
| 10383821 | Colcrys | formulation | 42 | 2036-11-22 |
| 10383820 | Colcrys | method of use | 62 | 2036-11-22 |
| 9399036 | Colcrys | method of use | 62 | 2033-08-22 |
| 9675613 | Colcrys | method of use | 62 | 2033-08-22 |
| 9789108 | Colcrys | method of use | 62 | 2033-08-22 |
| 8927607 | Colcrys | method of use | 62 | 2033-08-22 |
| 9555029 | Colcrys | method of use | 62 | 2033-08-22 |
| 10130585 | Colcrys | method of use | 70 | 2034-05-09 |
Related
- Chronic Gouty Arthritis — full disease profile
- AI Patent Landscape Report — type "chronic gouty arthritis" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner